Evogene’s First Quarter 2016 Earnings Announcement Schedule
REHOVOT, Israel, May 02, 2016 (GLOBE NEWSWIRE) — Evogene Ltd. (EVGN) (EVGN), a leading company for the improvement of crop productivity and economics for the food, feed and biofuel industries, announced today that it will release its financial results for the first quarter 2016 on Thursday, May 19, 2016.
On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial 1-888-668-9141 toll free from the United States, or 972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company’s website at www.evogene.com.
A replay of the conference call will be available approximately three hours following the completion of the call. To access the replay, please dial 1-877-456-0009 toll free from the United States, or 972-3-925-5904 internationally. The replay will be accessible through May 21, 2016, and an archive of the webcast will be available on the Company’s website through May 29, 2016.
About Evogene Ltd.:
Evogene (EVGN) (EVGN) is a leading biotechnology company for the improvement of crop productivity. The Company has developed a proprietary innovative technology platform, leveraging scientific understanding & computational technologies to harness Ag ‘Big Data’ for developing improved seed traits (via:GM and non-GM approaches), as well as innovative ag-chemical and novel ag-biological products. Evogene has strategic collaborations with world-leading agricultural companies like: BASF, Bayer, DuPont, Monsanto and Syngenta, focusing on innovative crop enhancement and crop protection solutions. For more information, please visit www.evogene.com.
This press release contains “forward-looking statements” relating to future events. These statements may be identified by words such as “may”,“expects”, “intends”, “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which beyond Evogene’s control, including, without limitation, those risk factors contained in Evogene’s reports filed with the appropriate securities authority. Evogene disclaims any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Evogene Company contact Eyal Leibovitz CFO (Israel) Tel. +972-8-931-1900 Eyal.Leibovitz@evogene.com Evogene IR advisory- PCG Vivian Cervantes Investor Relations (USA) 212-554-5482 firstname.lastname@example.org